Showing results (701-710 of 929) with videos related to
Sort By:
Pageof 93
ACS Chemical Biology|March 18, 2017
Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis AssaysPetar O Nikiforov, Michal Blaszczyk, Sachin Surade, et al.Journal of Medicinal Chemistry|September 14, 2019
Targeting of Fumarate Hydratase from Mycobacterium tuberculosis Using Allosteric Inhibitors with a Dimeric-Binding ModeAndrew J Whitehouse, M Daben J Libardo, Monica Kasbekar, et al.Critical Reviews in Oncogenesis|June 29, 2018
Radiation and Brain Tumors: An OverviewMichael Grunert, Rebecca Kassubek, Burkhardt Danz, et al.Journal of Medical Microbiology|May 21, 2011
Improved rapid molecular diagnosis of multidrug-resistant tuberculosis using a new reverse hybridization assay, REBA MTB-MDRHyeeun Bang, Sangjung Park, Joohwan Hwang, et al.Plos Pathogens|October 8, 2011
Evaluating the sensitivity of Mycobacterium tuberculosis to biotin deprivation using regulated gene expressionSae Woong Park, Marcus Klotzsche, Daniel J Wilson, et al.Frontiers in Microbiology|December 28, 2020
Development and Optimization of Chromosomally-Integrated Fluorescent Mycobacterium tuberculosis Reporter ConstructsKatharina Kolbe, Alice C Bell, Gareth A Prosser, et al.Molecular Ecology|April 20, 2023
The structure of root-associated fungal communities is related to the long-term effects of plant diversity on productivityJose G Maciá-Vicente, Davide Francioli, Alexandra Weigelt, et al.Molecular Therapy. Advances|May 15, 2026
Immune shielding of viral vectors via capsid engineering with genetically encoded zwitterionic peptidesShao-Chia Lu, Olivia X Ma, Alex A Anwar, et al.Lancet (London, England)|February 12, 2018
Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: a longitudinal studyOriol Mitjà, Charmie Godornes, Wendy Houinei, et al.Journal of Clinical Microbiology|October 24, 2014
Genotypic susceptibility testing of Mycobacterium tuberculosis isolates for amikacin and kanamycin resistance by use of a rapid sloppy molecular beacon-based assay identifies more cases of low-level drug resistance than phenotypic Lowenstein-Jensen testingSoumitesh Chakravorty, Jong Seok Lee, Eun Jin Cho, et al.Pageof 93